{
"generated_at": "2026-07-31T14:23:24+08:00",
"market_date": "2026-07-30",
"universe_count": 1992,
"scored_count": 514,
"candidate_count": 522,
"hot_seed": 120,
"macro": {
"regime": "mixed",
"regime_raw": -0.00838322694974334,
"spy_return_5d": 0.0047549510965501085,
"spy_return_20d": -0.005457529595208288,
"qqq_return_5d": -0.012153930736796048,
"vix_level": 17.09000015258789,
"vix_return_5d": -0.08609628581097906,
"tnx_return_5d": -0.008505201205405433,
"summary_en": "Regime=mixed; SPY 5d +0.5% / 20d -0.5%; VIX≈17.1 (5d -8.6%).",
"summary_zh": "宏观体制：中性/混杂。SPY 5日 +0.5% / 20日 -0.5%；VIX≈17.1（5日 -8.6%）。",
"themes": {
"monetary_policy": 0.5833333333333334,
"market": 0.25,
"economic_data": 0.08333333333333333,
"mega_cap": 0.08333333333333333
},
"headlines": [
{
"title": "A divided Fed holds interest rates steady despite stubborn inflation",
"link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQRGc4clFvdXhTQk1TMW1fdzBfc2hSYU5GWlNRTXg2N3ZjdC1BdDM5azhUTV92elNvdU9xLUptemxYbVpEMjJONTFZdFJ4eUJxcVpqd3cxR0poeFo5YWhOUzNEeHNQU1pQVEtOVGhvblJlLVlhTHJuUlZGMkdRNlREXzVQWTZQX0FGNEl1cy1WNE02a2FOUGRjVDV4Q3RFVUwzSnFxLVNPTQ?oc=5",
"source": "The Washington Post",
"published": "2026-07-30",
"age_days": 1,
"query": "FOMC Federal Reserve OR interest rates s",
"category": "monetary_policy"
},
{
"title": "A divided Federal Reserve holds interest rates steady despite high inflation",
"link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQbXhqTkhuVFhZUVVRaFdXYXp2OTJ2TXJtVEFFNEp6YVFLbUZKS25KT2JDaGdCbjdGWnVqRVN6NVBfMjI5SEwwU2F1VDF0VndmYWE0U1JzQnRwMjJhZjFNWU1vbjJ2WjduQ1F3cFQ1TVBSQllFUVotX2R4MEw2UXBtTWF1eEdUYjRjc1pBSU9n?oc=5",
"source": "NPR",
"published": "2026-07-29",
"age_days": 1,
"query": "FOMC Federal Reserve OR interest rates s",
"category": "monetary_policy"
},
{
"title": "Fed decision headlines two weeks of inflation and jobs data",
"link": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE5qdGh5bThPbktHR1d0eUZSaU5ELTI0OUg5bGpLSzU3bEJrVzR0ZUtDdGpXV0tYb3FZRTRVa2JueFFiQ2VTRXlpQWRRVkU5eHJqaWNNa1FhUTFEZzZNRUFOLQ?oc=5",
"source": "Kraken Blog",
"published": "2026-07-29",
"age_days": 1,
"query": "CPI inflation OR jobs report OR NFP stoc",
"category": "monetary_policy"
},
{
"title": "Fed’s Interest Rate Decision: July 29, 2026",
"link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOTF8tN3F6Z1lwQTNFTXFlSUtmWVFZM0NKNUhVLWRBTVdVd1pKdXdjTVQ1RHhaTG54OVNOUEJvbnd0NjY2c0otaDhxSDkyX2lEVjZENDNuSUxvbEI1eERJVzU5MXUwSmlEZTEwNTg3QXllRWpuZXVnVHZ5X3pqSTZybl94RWNVNThteVd1OThmNVJCSkl3bTdTYm11dXlQazdyYng3Qw?oc=5",
"source": "Advisor Perspectives",
"published": "2026-07-29",
"age_days": 1,
"query": "FOMC Federal Reserve OR interest rates s",
"category": "market"
},
{
"title": "Magnificent 7 results set to test broadening US stock market",
"link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPemNkZTJ3bTBNZXJZTXoyUm0yai0xOXA2dTh3VG9MemI4V0hzeHN0UU8wY205SHR1LUVnaGdoU1hDRmZFZWhpZ00xeFJRUWljR004bVcxVnJCR09fYUdxZFU3RU9BQ3I0T1FjXy1xTGZscmRTWlZBUEI2RkZDeEVsY3ZZQnYwZ2hBQ1VDTklXZVV2OHBhT0VvRFVwbk5zWXI2OUFrWA?oc=5",
"source": "Reuters",
"published": "2026-07-29",
"age_days": 1,
"query": "S&P 500 market news this week",
"category": "market"
},
{
"title": "The Fed holds interest rates for a fifth consecutive meeting, underscoring inflation fears",
"link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNbVA1MzJGNXllN1RjSG43b0xUam1seWRjUmI2bHdXdlZndHhEQ1pRZDI5WVE3MGg1NnBCMk9Gcm42MUZab29ZRFY3OTd3OTZERlZmLUtFbGhUOG5jQXlDREFuMGVkSmtyTlJvVzJhS1A0OG5zaGhWZkZ1VHlQRXNGcGcxczNOMW82ckdRdVJmRUZzRDI4OEV4SHRfSjh6Wms?oc=5",
"source": "NBC News",
"published": "2026-07-29",
"age_days": 1,
"query": "FOMC Federal Reserve OR interest rates s",
"category": "monetary_policy"
},
{
"title": "WATCH: Fed chair Warsh holds news conference after leaving interest rate unchanged",
"link": "https://news.google.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?oc=5",
"source": "PBS",
"published": "2026-07-29",
"age_days": 1,
"query": "FOMC Federal Reserve OR interest rates s",
"category": "monetary_policy"
},
{
"title": "Warsh-led Fed leaves rates on hold and a bond market scratching its head",
"link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPMWE0UWlwemdYNE5CaEZPSVBqZVNuSmlVSmIxWHV6R1hXa3lua1RReGpYaTEtZGttNzZoTU1XT3VGbjZWUmxFSWxnN21mMGlHVW1fazREOXdRZVk1ek9ya1JVMVNWM0NoVEVzRHY2bWJSYy1JRUtrNElLb3BPSjJzNm9wWmpmYTU3OXRIQ0E1dG82TkU2emF4QVoxTEJJU01ydzF5cHZHRVlnbGp6T3JESUtzV0ZZYjZUc2c?oc=5",
"source": "Reuters",
"published": "2026-07-30",
"age_days": 1,
"query": "FOMC Federal Reserve OR interest rates s",
"category": "monetary_policy"
},
{
"title": "Australia inflation undershoots forecasts, markets pare rate hike bets",
"link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOVWFacVNsRHpJMkVJckdiOFBSMEJtb19XTUs2NV9sNm16aUYwMlFnTEtiVElUMFBKMDJsUkVYYkc4bDRVSjB4aGkyUDV0VFhORU9fczg3dzFVdHZ6NE91T2xwTVctd0hkWXB3OU9FU09vLWFTVnYwYk5SYVpRX1FSUU5aQi0wYXZ2YUxwNDNHRG5NaWItVVNyZVhveFVBSUJ6S01lM2NINA?oc=5",
"source": "Reuters",
"published": "2026-07-29",
"age_days": 2,
"query": "CPI inflation OR jobs report OR NFP stoc",
"category": "monetary_policy"
},
{
"title": "CPI Could Come In Hotter Than Expected, Warn Experts: 'The Devil Will Be In The Details'",
"link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNUGJnMUpmN2NGdi03TGdreUVDMF9LZjI2U0hWa050LXRTTnFyWVhCUmlvS2tqVy1ZZFIxeEw2VlNWWWdLM0o4aURMeXFXU3EzVXVZSU1iY0E1dVJiWHd1MkRhSDlSSWNRdEpfQ0NNY25fbVFjZjlEZzV3UFo0OHhHODhoMjRWUlBuWmJGUGRPVk1GS0ZMU3ktWWtZUHlXWC1rdkRjMmZlQmZtSzdkS05PMDJ5ZDhJZVpIRzgzVzhjbTFsRDlsR000?oc=5",
"source": "Stocktwits",
"published": "2026-07-28",
"age_days": 2,
"query": "CPI inflation OR jobs report OR NFP stoc",
"category": "economic_data"
},
{
"title": "S&P 500 ends higher as investors await tech earnings",
"link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPNkhJQS14Y3d3QkMxeG5XZmR3cldUel9CSk9pdDZrSDFkc0gydEgxSXQ1d0xzTi1OR29xVWEwUjJtV1k4V1p3WlZJeUZCbnB2MzJOYjBHRExWTmVobWlibGFqajlUcWx5emx2M01vYmNwcHlDM2FvYjRwU3o2M0szNVpyM3JwakJyRkZReUMyVk5GUklTWWczOXdFSUcwNkh1clFNVWJn?oc=5",
"source": "Reuters",
"published": "2026-07-28",
"age_days": 2,
"query": "S&P 500 market news this week",
"category": "mega_cap"
},
{
"title": "What to Look Out for in Economic Data This Week (July 27-31)",
"link": "https://news.google.com/rss/articles/CBMifEFVX3lxTE1MeVNwMVVnVmhvRWo4b0N4WkhCRXQxTVRtb2ZmTWhCSmd4eERsN3Nfdllwejg0eG5ueFFCRUdPTzVUaXh4dEFZaWJqN3FFZnlFWTBlZ2ZvVkFFRzVScTR3TXRhZGl6MHp2RUF1clppVDRvR1lveC1FaXNCeXQ?oc=5",
"source": "kiplinger.com",
"published": "2026-07-28",
"age_days": 2,
"query": "CPI inflation OR jobs report OR NFP stoc",
"category": "market"
}
]
},
"top": [
{
"symbol": "LH",
"name": "Labcorp Holdings Inc. Common Stock",
"sector": "Health Care",
"industry": "Medical Specialities",
"exchange": "NYSE",
"market_cap": 25873460000.0,
"dollar_volume": 441392392.76,
"price": 315.5299987792969,
"last_date": "2026-07-30",
"return_1d": 0.027283102879164467,
"return_5d": 0.0842210524737308,
"return_20d": 0.11149074733019582,
"return_60d": 0.24710487976699969,
"return_120d": 0.13406169830759773,
"ma20_distance": 0.09839920859660123,
"ma50_distance": 0.15586121376198148,
"ma200_distance": 0.17691861784120344,
"high_52w": 315.5299987792969,
"near_52w_high": 1.0,
"volume_ratio": 1.3766408062896132,
"volume_ratio_1d": 1.816489453814983,
"volatility_20d": 0.29025009076039043,
"drawdown_52w": 0.0,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.1169482769254041,
"rs_60d": 0.21412484835558399,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.8,
"research_score": 65.9340926064227,
"heat_score": 49.86019417475728,
"breakdown": {
"research_quality": 65.9340926064227,
"market_heat": 49.86019417475728,
"macro_event": 11.200000000000001,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.9456310679611653,
"news": 9.85,
"relative_strength": 12.29514563106796,
"volume": 7.1611650485436895,
"liquidity": 2.283495145631068
},
"score": 58.92642270351008,
"is_near_high": true,
"is_high_volume": true,
"items": [
{
"title": "Labcorp Holdings Inc (LH) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ...",
"link": "https://finance.yahoo.com/healthcare/articles/labcorp-holdings-inc-lh-q2-210848327.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Labcorp Holdings Inc (LH) reports a 6% revenue increase to $3.7 billion and raises full-year 2026 guidance, driven by double-digit growth in specialty testing and robust Biopharma segment performance.",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 5.0,
"negative_hits": 0.0
},
{
"title": "LH Stock Down Despite Q2 Earnings and Revenue Beat, Margins Rise",
"link": "https://finance.yahoo.com/healthcare/articles/lh-stock-down-despite-q2-152900421.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Labcorp's Q2 earnings and revenues surpass estimates, margins expand, and its 2026 outlook is raised, but shares fall 6% in pre-market trading.",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Labcorp (LH) Q2 2026 Earnings Call Transcript",
"link": "https://www.fool.com/earnings/call-transcripts/2026/07/30/labcorp-lh-q2-2026-earnings-call-transcript/?.tsrc=rss",
"published": "2026-07-31",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Specialty testing and Central Labs fueled revenue growth and margin expansion.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Labcorp (LH) Reports Q2 Earnings: What Key Metrics Have to Say",
"link": "https://finance.yahoo.com/markets/stocks/articles/labcorp-lh-reports-q2-earnings-133008809.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "The headline numbers for Labcorp (LH) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Labcorp (NYSE:LH) Shares Slide on Q2 Revenue Miss Despite Earnings Beat",
"link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOUkdYZ2o0WWw2ZHFCbTZtQVM5R25kdm9jZzN2SkVNNmVsX0tpaGZvQUM5VV93TlpPeDdnMlctOC1GVzc2Qk41OWQ4Vi1JMl92TEQzTmU2RFVvV2NTdm1CSkE2Q0gyb3VzQ0JTejlhVThHTG5LZlBBVjBVaVpGcUdPdnEzRW1oNnMzS3VSQ01xbEJVVTNLUzNpQ0NhQUE0cnBJWTB5MklJYlRFUG9TeUd1RVJJajBZb3pyLUE?oc=5",
"published": "2026-07-30",
"age_days": 0,
"source": "ChartMill",
"snippet": "Labcorp (NYSE:LH) Shares Slide on Q2 Revenue Miss Despite Earnings Beat ChartMill",
"relevance": 1.35,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 1.0
},
{
"title": "Labcorp Holdings (LH) Surpasses Q2 Earnings and Revenue Estimates",
"link": "https://www.nasdaq.com/articles/labcorp-holdings-lh-surpasses-q2-earnings-and-revenue-estimates",
"published": "2026-07-30",
"age_days": 1,
"source": "Zacks",
"snippet": "Labcorp (LH) delivered earnings and revenue surprises of +4.18% and +0.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Labcorp Holdings Inc. Reveals Advance In Q2 Income",
"link": "https://www.nasdaq.com/articles/labcorp-holdings-inc-reveals-advance-q2-income",
"published": "2026-07-30",
"age_days": 1,
"source": "RTTNews",
"snippet": "(RTTNews) - Labcorp Holdings Inc. (LH) reported a profit for its second quarter that Increases, from the same period last year",
"relevance": 1.7,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength?",
"link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPRW12bU9Mc3JQVW1rcVRjMDgyZW5MaHAwQUhJOVlDOFMxN25WWV9BNEdLQ01QQ3dUN2pNUkZhNDdJa2dvbm9iV0RwbmZnR1BhMEl0RVV2a0pjeFd0NV9GTzhyQ0Zhb3VUeWlzQzZfMld5RDk3ZVpFZ3JmTmlBSFZwRFRDOEtzX1MwYVh0MzNSbS0yQW9kcVE?oc=5",
"published": "2026-07-24",
"age_days": 6,
"source": "Yahoo Finance",
"snippet": "Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength? Yahoo Finance",
"relevance": 1.6500000000000001,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Why Labcorp Holdings (LH) Stock Is Up Today",
"link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPbzZtT1ZBX0hmTXlVWEY0Q0RKNy1wYndxSGhHbmV5cy0wUFVndzY4eW9EOXlKWUFRVGdMaHlqYm1ZTGllWDFZajZSSTFjMHNHM1FqclBJSmI4a2F1ODVNanA0YlFkcGIxMXp4S3o4R1FKd05YQUF3eDZOYzd6SGNHbjNDT2tybVU?oc=5",
"published": "2026-07-23",
"age_days": 7,
"source": "quiverquant.com",
"snippet": "Why Labcorp Holdings (LH) Stock Is Up Today quiverquant.com",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 0.985,
"positive_hits": 10.0,
"negative_hits": 1.0,
"news_sources": [
"ChartMill",
"RTTNews",
"Yahoo Finance",
"Zacks",
"quiverquant.com"
],
"catalysts": [
"业绩/指引"
],
"news_errors": []
},
{
"symbol": "GKOS",
"name": "Glaukos Corporation Common Stock",
"sector": "Health Care",
"industry": "Medical/Dental Instruments",
"exchange": "NYSE",
"market_cap": 9897838682.0,
"dollar_volume": 431364351.44,
"price": 168.52000427246094,
"last_date": "2026-07-30",
"return_1d": 0.042434742391135094,
"return_5d": 0.1077367965791749,
"return_20d": 0.22497634150226253,
"return_60d": 0.24048580567638167,
"return_120d": 0.4844962055656812,
"ma20_distance": 0.0931464484838489,
"ma50_distance": 0.224198655636499,
"ma200_distance": 0.4427421726810554,
"high_52w": 168.52000427246094,
"near_52w_high": 1.0,
"volume_ratio": 1.7260809451076058,
"volume_ratio_1d": 2.779293920068335,
"volatility_20d": 0.40121399135797114,
"drawdown_52w": 0.0,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.23043387109747082,
"rs_60d": 0.20750577426496597,
"entry_setup_score": 0.8688602983253506,
"overheat_score": 0.016794622545995952,
"macro_fit": 0.6983205377454005,
"research_score": 65.54437907355548,
"heat_score": 53.413012696655585,
"breakdown": {
"research_quality": 65.54437907355548,
"market_heat": 53.413012696655585,
"macro_event": 9.776487528435606,
"entry_setup": 6.082022088277454,
"overheat_penalty": -0.13435698036796762,
"near_52w_high": 3.9533980582524273,
"news": 10.0,
"relative_strength": 12.84271844660194,
"volume": 7.844660194174757,
"liquidity": 2.2135922330097086
},
"score": 58.23934204558247,
"is_near_high": true,
"is_high_volume": true,
"items": [
{
"title": "Glaukos Q2 Earnings Beat Estimates on iDose TR Growth, Stock Up",
"link": "https://finance.yahoo.com/healthcare/articles/glaukos-q2-earnings-beat-estimates-155500301.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "GKOS' Q2 loss narrows as revenues jump 50% on iDose TR and Epioxa growth, lifting its 2026 sales outlook and shares by 9.8%.",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates",
"link": "https://finance.yahoo.com/markets/stocks/articles/glaukos-gkos-reports-q2-loss-222511819.html?.tsrc=rss",
"published": "2026-07-29",
"age_days": 1,
"source": "Yahoo Finance",
"snippet": "Glaukos (GKOS) delivered earnings and revenue surprises of +50.00% and +24.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Glaukos Corporation (GKOS) Stock Rises on Q2 2026 Earnings",
"link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQaE5Hbi1aaS1yeVhoeDF4M0xDRU9FWXhIa1FBQTQtLUZUNkJtdFRGNEk1Sm0yUGl0Q3ljMUVYRXI3N0paSjBDN0I2dnUydXpVUFF3NnVSd3dqcjhKVVZKeTRocVdpSHZMUHFsZDV3T2xqRGNVOEpqalpCMUFoNV9LS3JFdG9ORnlYX3RLTUpma3dVRjgxMWItTTNnOA?oc=5",
"published": "2026-07-29",
"age_days": 1,
"source": "quiverquant.com",
"snippet": "Glaukos Corporation (GKOS) Stock Rises on Q2 2026 Earnings quiverquant.com",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Glaukos Corp (GKOS) (Q2 2026) Earnings Call Highlights: Record Revenue Surge and Raised ...",
"link": "https://finance.yahoo.com/healthcare/articles/glaukos-corp-gkos-q2-2026-050324183.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 1,
"source": "Yahoo Finance",
"snippet": "Glaukos Corp (GKOS) posts a 50% revenue jump to $185.6 million, driven by iDose TR and Epioxa, while navigating LCD challenges and a Q3 corneal health transition.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 3.0,
"negative_hits": 0.0
},
{
"title": "Glaukos Q2 Earnings Call Highlights",
"link": "https://www.marketbeat.com/instant-alerts/glaukos-q2-earnings-call-highlights-2026-07-29/?utm_source=yahoofinance&utm_medium=yahoofinance&.tsrc=rss",
"published": "2026-07-30",
"age_days": 1,
"source": "Yahoo Finance",
"snippet": "Glaukos (NYSE:GKOS) reported record second-quarter 2026 consolidated net sales of $185.6 million, up 50% from the prior-year period on a reported basis and 49% on a constant-currency basis, as growth in its U.S. glaucoma, international glaucoma and corneal health businesses exceeded management’s exp",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Glaukos (GKOS) Reports Q2 Earnings: What Key Metrics Have to Say",
"link": "https://finance.yahoo.com/markets/stocks/articles/glaukos-gkos-reports-q2-earnings-023001417.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 1,
"source": "Yahoo Finance",
"snippet": "Although the revenue and EPS for Glaukos (GKOS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Glaukos Raises 2026 Sales Guidance to $680M-$700M Range",
"link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQNlY5THBRZVdDZW52NHlKZDdNUTVpdjhEYnpvZmIxN21VZ0VnbTJGN2Q5Z0pFZnI4d095Q0FwWVRYeWN5MDhQU1NnSUJIQnBjRHJFR2FtMmJCa1JZZmR4WHZPY243dVlleFd6cGpxR3B1WDg0Mk9KSExBTU00NGp2SHhMWVNrSVBKSENVQVdOWlZ2eUdWeFFXc214dTNlTXBPOXlONg?oc=5",
"published": "2026-07-29",
"age_days": 1,
"source": "stocktitan.net",
"snippet": "Glaukos Raises 2026 Sales Guidance to $680M-$700M Range stocktitan.net",
"relevance": 0.7,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Notable Wednesday Option Activity: FCF, GKOS, SNOW",
"link": "https://www.nasdaq.com/articles/notable-wednesday-option-activity-fcf-gkos-snow",
"published": "2026-07-29",
"age_days": 2,
"source": "BNK Invest",
"snippet": "Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in First Commonwealth Financial Corp (Symbol: FCF), where a total of 6,386 contracts have traded so far, representing approximately 638,600 underlying shares. That amounts",
"relevance": 1.35,
"category": "产品/订单",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Notable ETF Outflow Detected - IWO, FROG, GKOS, KRYS",
"link": "https://www.nasdaq.com/articles/notable-etf-outflow-detected-iwo-frog-gkos-krys",
"published": "2026-07-23",
"age_days": 8,
"source": "BNK Invest",
"snippet": "Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 2000 Growth ETF (Symbol: IWO) where we have detected an approximate $225.7 million dollar outflow -- that's a 1.5% decrease week ove",
"relevance": 1.0,
"category": "市场观点",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
}
],
"news_score": 1.0,
"positive_hits": 10.65,
"negative_hits": 0.0,
"news_sources": [
"BNK Invest",
"Yahoo Finance",
"quiverquant.com",
"stocktitan.net"
],
"catalysts": [
"业绩/指引"
],
"news_errors": []
},
{
"symbol": "BMY",
"name": "Bristol-Myers Squibb Company Common Stock",
"sector": "Health Care",
"industry": "Biotechnology: Pharmaceutical Preparations",
"exchange": "NYSE",
"market_cap": 132448741080.0,
"dollar_volume": 1168777394.58,
"price": 64.86000061035156,
"last_date": "2026-07-30",
"return_1d": 0.02789226907750697,
"return_5d": 0.05446272769033067,
"return_20d": 0.14918501397088968,
"return_60d": 0.1303589997036929,
"return_120d": 0.08971774380911235,
"ma20_distance": 0.0794797406748684,
"ma50_distance": 0.11863460725645059,
"ma200_distance": 0.1695400383119139,
"high_52w": 64.86000061035156,
"near_52w_high": 1.0,
"volume_ratio": 1.0477900184983402,
"volume_ratio_1d": 1.4270725109596332,
"volatility_20d": 0.3025355306130333,
"drawdown_52w": 0.0,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.15464254356609797,
"rs_60d": 0.09737896829227721,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.8,
"research_score": 63.911277072442125,
"heat_score": 49.81941747572816,
"breakdown": {
"research_quality": 63.911277072442125,
"market_heat": 49.81941747572816,
"macro_event": 11.200000000000001,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.883495145631068,
"news": 10.0,
"relative_strength": 11.095145631067961,
"volume": 4.47378640776699,
"liquidity": 4.718446601941747
},
"score": 57.94323823749067,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "Bristol-Myers Squibb (NYSE:BMY) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales",
"link": "https://finance.yahoo.com/healthcare/articles/bristol-myers-squibb-nyse-bmy-140055279.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 5.7% year on year to $12.97 billion. The company’s full-year revenue guidance of $49.5 billion at the midpoint came in 4.3% above analysts’ estimates. Its non-GAAP profit of $2.04 per share was 27.7% above analysts’ consensus estimates.",
"relevance": 2.3,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 3.0,
"negative_hits": 0.0
},
{
"title": "Bristol-Myers Squibb (BMY) Q2 2026 Earnings Call Transcript",
"link": "https://www.fool.com/earnings/call-transcripts/2026/07/30/bristol-myers-squibb-bmy-q2-2026-earnings-call-transcript/?.tsrc=rss",
"published": "2026-07-31",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Growth portfolio now drives 60% of revenue as Eliquis surges 21%.",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Bristol-Myers Squibb Co (BMY) (Q2 2026) Earnings Call Highlights: Growth Portfolio Surges 14%, ...",
"link": "https://finance.yahoo.com/healthcare/articles/bristol-myers-squibb-co-bmy-210603184.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Strong revenue growth driven by Eliquis and key growth assets, offset by Opdivo decline and delayed readouts for Milvexian and Cobenfy.",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 3.0,
"negative_hits": 0.0
},
{
"title": "Bristol Myers Squibb Lifts Full-Year Guidance After Strong Second-Quarter Earnings Beat",
"link": "https://investorshub.advfn.com/market-news/article/33088/bristol-myers-squibb-lifts-full-year-guidance-after-strong-second-quarter-earnings-beat?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Bristol Myers Squibb (NYSE:BMY) reported second-quarter results that comfortably exceeded Wall Street expectations, driven by continued strength across its growth portfolio. The pharmaceutical company also raised its full-year 2026 financial outlook, sending its shares more than 1% higher in premarket trading on Thursday.",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 5.0,
"negative_hits": 0.0
},
{
"title": "Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Beat Estimates",
"link": "https://www.nasdaq.com/articles/bristol-myers-squibb-bmy-q2-earnings-and-revenues-beat-estimates",
"published": "2026-07-30",
"age_days": 1,
"source": "Zacks",
"snippet": "Bristol Myers (BMY) delivered earnings and revenue surprises of +28.30% and +11.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"relevance": 1.35,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Noteworthy Thursday Option Activity: JPM, BMY, CI",
"link": "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-jpm-bmy-ci",
"published": "2026-07-30",
"age_days": 1,
"source": "BNK Invest",
"snippet": "Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in JPMorgan Chase & Co (Symbol: JPM), where a total volume of 44,608 contracts has been traded thus far today, a contract volume which is representative of appro",
"relevance": 1.0,
"category": "产品/订单",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "BMY Q2 Earnings Beat Estimates, '26 View Raised, Stock Up",
"link": "https://www.nasdaq.com/articles/bmy-q2-earnings-beat-estimates-26-view-raised-stock",
"published": "2026-07-30",
"age_days": 1,
"source": "Zacks",
"snippet": "Bristol Myers??? tops Q2 earnings and revenue estimates, raises 2026 guidance, and sees strong momentum from its Growth Portfolio and higher Eliquis demand.",
"relevance": 1.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 6.0,
"negative_hits": 0.0
},
{
"title": "Bristol Myers Squibb (BMY) Stock Still Looks Cheap After Fresh AI Drug Discovery News",
"link": "https://news.google.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?oc=5",
"published": "2026-07-29",
"age_days": 2,
"source": "simplywall.st",
"snippet": "Bristol Myers Squibb (BMY) Stock Still Looks Cheap After Fresh AI Drug Discovery News simplywall.st",
"relevance": 1.35,
"category": "医药/审批",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Bristol-Myers Squibb stock hits 52-week high at 62.89 USD",
"link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNVWZqcmF0NGpDelEtbzJKQUx5OGs3MHNGMlM0VG5OVEpaU3daYlViQ1B6NTlsMVVGNklBWldaWWN5QlR6cGhuU0VVaWtiYjRSLUl2NWhLWERYWXlsS2p5b0Zad0NMMi04Mm1rT2xjbWdCTGtCNzRUdVdQMGZFazdFMlhPLUg1TDdkTUlXSmNjMHdJR3hpd1BmSkxTa0FhbEt5dVl4bkJuZktqTVh6MVF5YQ?oc=5",
"published": "2026-07-27",
"age_days": 3,
"source": "Investing.com",
"snippet": "Bristol-Myers Squibb stock hits 52-week high at 62.89 USD Investing.com",
"relevance": 0.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 1.0,
"positive_hits": 21.0,
"negative_hits": 0.0,
"news_sources": [
"BNK Invest",
"Investing.com",
"Yahoo Finance",
"Zacks",
"simplywall.st"
],
"catalysts": [
"业绩/指引",
"分析师/评级"
],
"news_errors": []
},
{
"symbol": "BAX",
"name": "Baxter International Inc. Common Stock",
"sector": "Health Care",
"industry": "Medical/Dental Instruments",
"exchange": "NYSE",
"market_cap": 13815545964.0,
"dollar_volume": 606445745.75,
"price": 26.75,
"last_date": "2026-07-30",
"return_1d": 0.07993538577492187,
"return_5d": 0.23442546865809,
"return_20d": 0.23328719877148818,
"return_60d": 0.6095065372592274,
"return_120d": 0.2287551418245537,
"ma20_distance": 0.17080643689655672,
"ma50_distance": 0.26867441308987416,
"ma200_distance": 0.36773375600699465,
"high_52w": 26.75,
"near_52w_high": 1.0,
"volume_ratio": 1.4792673149883917,
"volume_ratio_1d": 3.3783413255924155,
"volatility_20d": 0.49744326572918285,
"drawdown_52w": 0.0,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.23874472836669647,
"rs_60d": 0.5765265058478117,
"entry_setup_score": 0.5440279277451137,
"overheat_score": 0.19469765235949665,
"macro_fit": 0.6805302347640504,
"research_score": 63.08227969729651,
"heat_score": 55.272740617611106,
"breakdown": {
"research_quality": 63.08227969729651,
"market_heat": 55.272740617611106,
"macro_event": 9.527423286696706,
"entry_setup": 3.808195494215796,
"overheat_penalty": -1.5575812188759732,
"near_52w_high": 3.9145631067961166,
"news": 10.0,
"relative_strength": 13.685436893203883,
"volume": 7.425242718446602,
"liquidity": 3.297087378640777
},
"score": 57.34148205535203,
"is_near_high": true,
"is_high_volume": true,
"items": [
{
"title": "Baxter (NYSE:BAX) Reports Upbeat Q2 CY2026, Stock Jumps 16.1%",
"link": "https://finance.yahoo.com/healthcare/articles/baxter-nyse-bax-reports-upbeat-132702600.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Healthcare company Baxter International (NYSE:BAX) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 5.3% year on year to $2.96 billion. Its non-GAAP profit of $0.56 per share was 52.5% above analysts’ consensus estimates.",
"relevance": 2.3,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 3.0,
"negative_hits": 0.0
},
{
"title": "Why Are Baxter (BAX) Shares Soaring Today",
"link": "https://finance.yahoo.com/markets/stocks/articles/why-baxter-bax-shares-soaring-230902343.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Shares of healthcare company Baxter International (NYSE:BAX) jumped 8.7% in the afternoon session after the company reported second-quarter results that beat analyst expectations on the top and bottom lines and raised its full-year financial forecast.",
"relevance": 2.0,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "Baxter International Inc (BAX) (Q2 2026) Earnings Call Highlights: Strong Revenue Beat Offsets ...",
"link": "https://finance.yahoo.com/healthcare/articles/baxter-international-inc-bax-q2-210609982.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Baxter International Inc (BAX) delivered a 5% organic revenue beat in Q2 2026, driven by broad-based growth, but adjusted EPS fell 5% year-over-year due to cost headwinds.",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 3.0,
"negative_hits": 0.0
},
{
"title": "BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract",
"link": "https://finance.yahoo.com/markets/stocks/articles/bax-stock-gains-q2-earnings-160200383.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Baxter beats second-quarter earnings and revenue estimates, posts broad-based segment growth and raises its 2026 outlook despite margin pressure.",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 5.0,
"negative_hits": 0.0
},
{
"title": "Why Baxter International (BAX) Stock Is Up Today",
"link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPMW1uU3gyOTFHSHRCNnE2Y1VUTUtXMVc2eEQ1RmhsVVQ2bWNudklhQUMxMWZNZHVhVWNrd3hvbWFRRW9scjRCd0FEbExCcWdpVWZlV185ZGFreU5VRkxDQ1pTdW5oUEFleEZZYzBmbXl2dGdfUlpPVU5nZ051a1YwRVVzMjRIZVluS1VRYkp3?oc=5",
"published": "2026-07-30",
"age_days": 0,
"source": "quiverquant.com",
"snippet": "Why Baxter International (BAX) Stock Is Up Today quiverquant.com",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Baxter International stock hits 52-week high at 29.04 USD",
"link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPNzY0QWhpZEloTHJfNV9SVHNscDlNTzIxT2d4ZWx5bm1EN0J4Q2NYUXREQzhhN2s4NUdCNlg1RlVTVkszWHRiQ2FSbWdhdGp5NENsd1B0MWNRWXAzTEc2YkVHWmIxOUZLeklucE1oUVJXOFpNbVpnOTJtS18tRld2QTd0dmFVSFNsS1dsdTBwQUJYQmxRUWw1UUk4MDFBYm11eUJUSlJ0UFQ1ejc2MGxKR0lB?oc=5",
"published": "2026-07-30",
"age_days": 0,
"source": "Investing.com",
"snippet": "Baxter International stock hits 52-week high at 29.04 USD Investing.com",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Baxter International (NYSE:BAX) Jumps After Q2 Earnings Beat and Raised Outlook",
"link": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPNlRKU01vSEtGTEx1c3BRR0VHWWVHNlkydEE0WnhaeWdyNTVibWNnanI4VTdUWE1Qb0hHZ29oWXBQbE9KMWE5S2V0Z2hNdTlLQUd4T0lTazhpeUw1NkEzUzRvOGx1M1lYeUpyY1QyalhlMS1Eak9yODd3d3EwRzctdFZvQ3FzZDJISWlHcGMtVkRjV0tOakpMVmtVbXZUUC1BeDVPWHRBa01lVC12alEtNTdJUWlhM3ZFVVVWY2hLWXotRWtOTnc?oc=5",
"published": "2026-07-30",
"age_days": 0,
"source": "ChartMill",
"snippet": "Baxter International (NYSE:BAX) Jumps After Q2 Earnings Beat and Raised Outlook ChartMill",
"relevance": 1.7,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 3.0,
"negative_hits": 0.0
},
{
"title": "Baxter’s shares soar by 17% after reporting positive Q2",
"link": "https://www.medicaldevice-network.com/news/baxter-shares-soar-by-17-after-reporting-positive-q2/?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Baxter’s profits rose 5% in Q2 versus the same period in 2025 that was impacted by factors including hurricane damage to a key facility in North Carolina.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates",
"link": "https://finance.yahoo.com/markets/stocks/articles/baxter-bax-q2-earnings-taking-140004239.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 1.0,
"positive_hits": 17.0,
"negative_hits": 0.0,
"news_sources": [
"ChartMill",
"Investing.com",
"Yahoo Finance",
"quiverquant.com"
],
"catalysts": [
"业绩/指引",
"分析师/评级",
"市场观点"
],
"news_errors": []
},
{
"symbol": "NBIX",
"name": "Neurocrine Biosciences Inc. Common Stock",
"sector": "Health Care",
"industry": "Biotechnology: Biological Products (No Diagnostic Substances)",
"exchange": "NASDAQ",
"market_cap": 18652021847.0,
"dollar_volume": 402742574.5,
"price": 185.5,
"last_date": "2026-07-30",
"return_1d": 0.026052364006744266,
"return_5d": 0.06517373816425232,
"return_20d": 0.10568036762248201,
"return_60d": 0.38360550358895074,
"return_120d": 0.34488515805287534,
"ma20_distance": 0.05321129247758982,
"ma50_distance": 0.11007915841749782,
"ma200_distance": 0.27259717283666896,
"high_52w": 185.5,
"near_52w_high": 1.0,
"volume_ratio": 1.1086310582389862,
"volume_ratio_1d": 1.7818897163838532,
"volatility_20d": 0.30268077897856105,
"drawdown_52w": 0.0,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.1111378972176903,
"rs_60d": 0.35062547217753504,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.8,
"research_score": 64.06661687826737,
"heat_score": 46.89514563106796,
"breakdown": {
"research_quality": 64.06661687826737,
"market_heat": 46.89514563106796,
"macro_event": 11.200000000000001,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.9611650485436893,
"news": 10.0,
"relative_strength": 12.648543689320388,
"volume": 5.172815533980582,
"liquidity": 1.8407766990291263
},
"score": 57.140519790888725,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "Neurocrine Biosciences (NBIX) Surpasses Q2 Earnings and Revenue Estimates",
"link": "https://finance.yahoo.com/healthcare/articles/neurocrine-biosciences-nbix-surpasses-q2-211502156.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Neurocrine (NBIX) delivered earnings and revenue surprises of +26.11% and +6.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"relevance": 2.3,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Neurocrine Biosciences Inc (NBIX) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised ...",
"link": "https://finance.yahoo.com/healthcare/articles/neurocrine-biosciences-inc-nbix-q2-050502020.html?.tsrc=rss",
"published": "2026-07-31",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Neurocrine Biosciences Inc (NBIX) posts nearly 40% revenue growth in Q2 2026, driven by INGREZZA's record sales and successful launches of CRENESSITY and VYKAT XR.",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 4.0,
"negative_hits": 0.0
},
{
"title": "Neurocrine Biosciences Reports Second-Quarter 2026 Financial Results",
"link": "https://finance.yahoo.com/healthcare/articles/neurocrine-biosciences-reports-second-quarter-200100564.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the second quarter ended June 30, 2026.",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Neurocrine Q2 Revenue Jumps 39%; Raises FY26 INGREZZA Sales Guidance",
"link": "https://www.nasdaq.com/articles/neurocrine-q2-revenue-jumps-39-raises-fy26-ingrezza-sales-guidance",
"published": "2026-07-31",
"age_days": 0,
"source": "RTTNews",
"snippet": "(RTTNews) - Neurocrine Biosciences, Inc. (NBIX), which develops pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders, reported second-quarter financial results reflecting strong earnings backed by 39% revenue growth.",
"relevance": 1.7,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 5.0,
"negative_hits": 0.0
},
{
"title": "Neurocrine (NBIX) Q2 2026 Earnings Call Transcript",
"link": "https://www.fool.com/earnings/call-transcripts/2026/07/30/neurocrine-nbix-q2-2026-earnings-call-transcript/?.tsrc=rss",
"published": "2026-07-31",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Revenue hit $950 million as INGREZZA surged 15% and CRENESSITY grew 20%.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Neurocrine (NBIX) Reports Q2 Earnings: What Key Metrics Have to Say",
"link": "https://finance.yahoo.com/markets/stocks/articles/neurocrine-nbix-reports-q2-earnings-213002366.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "The headline numbers for Neurocrine (NBIX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Neurocrine Biosciences Inc Q2 Profit Climbs",
"link": "https://www.nasdaq.com/articles/neurocrine-biosciences-inc-q2-profit-climbs",
"published": "2026-07-30",
"age_days": 1,
"source": "RTTNews",
"snippet": "(RTTNews) - Neurocrine Biosciences Inc (NBIX) released earnings for its second quarter that Increases, from last year",
"relevance": 1.7,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Neurocrine Biosciences Q2 26 Earnings Conference Call At 4:30 PM ET",
"link": "https://www.nasdaq.com/articles/neurocrine-biosciences-q2-26-earnings-conference-call-4-30-pm-et",
"published": "2026-07-30",
"age_days": 1,
"source": "RTTNews",
"snippet": "(RTTNews) - Neurocrine Biosciences Inc (NBIX) will host a conference call at 4:30 PM ET on July 30, 2026, to discuss Q2 26 earnings results.",
"relevance": 1.7,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Neurocrine Biosciences (NBIX) Stock Trades Fair On Earnings But Mixed On Value",
"link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNNW16OEZCcDdTSnBOalRoUXNLd0tSS3RGbUpteDAtandFVFdsR2lTdUR2NUNZdTFBdXp2Y3JOa3FUbVlMRm1ZckFrVXVDMHdNSFJaVll0aXdCN1RLRV9fcmRtWEVtRWd3cXRSbDlFWEp6VnVxRk11bU5tV0tud0hIbHpiM3JWLU94VnRucVdyajVncEl6Z1htTmo4eE9PbHNFOVJ3?oc=5",
"published": "2026-07-23",
"age_days": 7,
"source": "Yahoo Finance",
"snippet": "Neurocrine Biosciences (NBIX) Stock Trades Fair On Earnings But Mixed On Value Yahoo Finance",
"relevance": 2.3,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 1.0,
"positive_hits": 11.0,
"negative_hits": 0.0,
"news_sources": [
"RTTNews",
"Yahoo Finance"
],
"catalysts": [
"业绩/指引"
],
"news_errors": []
},
{
"symbol": "AMGN",
"name": "Amgen Inc. Common Stock",
"sector": "Health Care",
"industry": "Biotechnology: Biological Products (No Diagnostic Substances)",
"exchange": "NASDAQ",
"market_cap": 209212515333.0,
"dollar_volume": 1164824087.68,
"price": 387.6400146484375,
"last_date": "2026-07-30",
"return_1d": 0.0,
"return_5d": 0.043445530682200584,
"return_20d": 0.07281440526362148,
"return_60d": 0.19697393034642086,
"return_120d": 0.05394243478506189,
"ma20_distance": 0.04707858866726977,
"ma50_distance": 0.09301824116324542,
"ma200_distance": 0.1289437991804694,
"high_52w": 393.1000061035156,
"near_52w_high": 0.9861104264301631,
"volume_ratio": 1.1217409736451636,
"volume_ratio_1d": 1.1374039830020894,
"volatility_20d": 0.27791195944855474,
"drawdown_52w": -0.013889573569836888,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.07827193485882977,
"rs_60d": 0.16399389893500516,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.7884253553584694,
"research_score": 65.01224794622853,
"heat_score": 45.8,
"breakdown": {
"research_quality": 65.01224794622853,
"market_heat": 45.8,
"macro_event": 11.037954975018572,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.766990291262136,
"news": 10.0,
"relative_strength": 11.382524271844659,
"volume": 5.374757281553398,
"liquidity": 4.706796116504854
},
"score": 57.087629486710114,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND",
"link": "https://finance.yahoo.com/markets/stocks/articles/amgen-announces-2026-third-quarter-200100315.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.52 per share dividend for the third quarter of 2026. The dividend will be paid on September 11, 2026, to all stockholders of record as of the close of business on August 21, 2026.",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Amgen (AMGN) Stock Still Looks Below Fair Value Today",
"link": "https://finance.yahoo.com/markets/stocks/articles/amgen-amgn-stock-still-looks-071054137.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Amgen stock has nearly doubled investors' money over the past five years, yet current checks suggest a mixed picture where the Discounted Cash Flow (DCF) intrinsic value points to meaningful upside while market multiples look closer to fair. Amgen has delivered a 93.9% return over five years, which puts more focus on whether the current share price still leaves room relative to intrinsic value estimates. Confidence around Amgen's portfolio of established and late stage products can support...",
"relevance": 2.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "FIRST AMGEN SCHOLARS PROGRAM IN INDIA LAUNCHES AT IIIT HYDERABAD",
"link": "https://finance.yahoo.com/healthcare/articles/first-amgen-scholars-program-india-060400004.html?.tsrc=rss",
"published": "2026-07-31",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Amgen (NASDAQ: AMGN) today announced the launch of the first Amgen Scholars Program in India at the International Institute of Information Technology Hyderabad (IIIT Hyderabad), bringing the globally respected undergraduate summer research program to India for the first time.",
"relevance": 1.6500000000000001,
"category": "产品/订单",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "What Analyst Projections for Key Metrics Reveal About Amgen (AMGN) Q2 Earnings",
"link": "https://finance.yahoo.com/markets/stocks/articles/analyst-projections-key-metrics-reveal-131504282.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Besides Wall Street's top-and-bottom-line estimates for Amgen (AMGN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.",
"relevance": 1.6500000000000001,
"category": "分析师/评级",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Are Wall Street Analysts Bullish on Amgen Stock?",
"link": "https://www.barchart.com/story/news/3545321/are-wall-street-analysts-bullish-on-amgen-stock?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Amgen has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.",
"relevance": 1.0,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Amgen (AMGN) Wins Backing In Europe For Broader Repatha Use",
"link": "https://finance.yahoo.com/healthcare/articles/amgen-amgn-wins-backing-europe-042820027.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 1,
"source": "Yahoo Finance",
"snippet": "Amgen (NasdaqGS:AMGN) received a positive opinion from the European Medicines Agency’s CHMP for an expanded Repatha indication in Europe. The recommendation covers use of Repatha to help reduce cardiovascular risk in high risk adults without a prior heart attack or stroke. The CHMP view is based on Phase 3 clinical data that showed a significant reduction in major adverse cardiovascular events. Amgen is a large biotech company with a focus on cardiometabolic, oncology and immunology...",
"relevance": 1.6500000000000001,
"category": "医药/审批",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Amgen (AMGN) Stock Moves -1.44%: What You Should Know",
"link": "https://www.nasdaq.com/articles/amgen-amgn-stock-moves-144-what-you-should-know",
"published": "2026-07-29",
"age_days": 2,
"source": "Zacks",
"snippet": "In the closing of the recent trading day, Amgen (AMGN) stood at $387.42, denoting a -1.44% move from the preceding trading day.",
"relevance": 1.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Amgen stock jumps as investors appear to look past Tavneos overhang and toward earnings",
"link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQZzF0SHNiNVFrYTJuLXZYQjEyRlIyMXFJbFJGMVJXNU85c2cwWW9XNkdzcDN1bzhhdjVVbEJMUV9Cei11a0ZhWHBIMFgzelpTQ0pqZ3hOMnRBMkRKcW1qR2ZxaHhHLXQ4N1BWVTNJQUc5U1ZnYWdZakhQMmtoVWE3NmNOcE16R01OQjFlNGV0LV9NRXNULWt0cUdIbUdEUVNuUHZCNGFVTXdDNWZXSWR6UnZiQ2FiWFNZNEFVZQ?oc=5",
"published": "2026-07-28",
"age_days": 2,
"source": "quiverquant.com",
"snippet": "Amgen stock jumps as investors appear to look past Tavneos overhang and toward earnings quiverquant.com",
"relevance": 0.7,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Amgen stock hits all-time high at 391.3 USD",
"link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNQVM5a0xQanN1UGgwWmE2NWp5UEZ2dG9PYzVkcFRYSnlucV9JUVRRZXNMMDhyT3pNU1hTNUhZLW4zMWNMOThjWXhKWURQR0twSGZVUDVRdmpRVEl1el9ZV2RMNk10d2QyOHlMNmNPWlg5WVFxX3IyTkxRMVliU0FhZlluY05VZGxtc3A2SW1iY1RKbFZXMEx1MkhlWnBrRTA?oc=5",
"published": "2026-07-28",
"age_days": 2,
"source": "Investing.com",
"snippet": "Amgen stock hits all-time high at 391.3 USD Investing.com",
"relevance": 0.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 1.0,
"positive_hits": 4.0,
"negative_hits": 0.0,
"news_sources": [
"Investing.com",
"Yahoo Finance",
"Zacks",
"quiverquant.com"
],
"catalysts": [
"业绩/指引",
"产品/订单",
"分析师/评级",
"市场观点"
],
"news_errors": []
},
{
"symbol": "ILMN",
"name": "Illumina Inc. Common Stock",
"sector": "Health Care",
"industry": "Medical Specialities",
"exchange": "NASDAQ",
"market_cap": 31030117000.0,
"dollar_volume": 566982995.13,
"price": 205.08999633789062,
"last_date": "2026-07-30",
"return_1d": 0.05271526859446518,
"return_5d": 0.04180633801697908,
"return_20d": 0.11528629625649778,
"return_60d": 0.4715505741780597,
"return_120d": 0.5349898615448481,
"ma20_distance": 0.07006362266632649,
"ma50_distance": 0.17763316979683208,
"ma200_distance": 0.4740068504253694,
"high_52w": 205.08999633789062,
"near_52w_high": 1.0,
"volume_ratio": 1.0042827857788523,
"volume_ratio_1d": 1.4444605065844132,
"volatility_20d": 0.3711017308173075,
"drawdown_52w": 0.0,
"trend_score": 1.0,
"sector_score": 0.9230769230769231,
"rs_20d": 0.12074382585170607,
"rs_60d": 0.438570542766644,
"entry_setup_score": 0.9865308911387127,
"overheat_score": 0.0,
"macro_fit": 0.8,
"research_score": 63.34709039779175,
"heat_score": 46.83106796116505,
"breakdown": {
"research_quality": 63.34709039779175,
"market_heat": 46.83106796116505,
"macro_event": 11.200000000000001,
"entry_setup": 6.905716237970989,
"overheat_penalty": -0.0,
"near_52w_high": 3.9223300970873787,
"news": 10.0,
"relative_strength": 12.893203883495145,
"volume": 3.759223300970874,
"liquidity": 3.110679611650485
},
"score": 56.775923779289556,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "Illumina (ILMN) Tops Q2 Earnings and Revenue Estimates",
"link": "https://finance.yahoo.com/healthcare/articles/illumina-ilmn-tops-q2-earnings-220011740.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Illumina (ILMN) delivered earnings and revenue surprises of +6.50% and +3.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Illumina (ILMN) Stock Rises on Q2 2026 Earnings",
"link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOemJaTnlMaEFYbEhaeTNhNHVLVEYzTnVGX3dhSkxDckthWm5VT0ExTWU4SlVFdXVKbFlfdGlVMUZEQ2ZmUkFQNUFSQ1VwYlBFUC1Ja0lweGY3M2JqZWd5dkxkSW5JQmNVTXNEaXFhcU1sV3haWVZ2dGpoeEtFd1ZtVmczaGM1Tm8?oc=5",
"published": "2026-07-30",
"age_days": 0,
"source": "quiverquant.com",
"snippet": "Illumina (ILMN) Stock Rises on Q2 2026 Earnings quiverquant.com",
"relevance": 1.7,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full-Year Outlook Slightly Exceeds Expectations",
"link": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxPNnpfV0JwUXdualZDVGdVcmJZVzJBRG5IaE1UazhkLU5jWkJUbGlTbDdLanpWLWs1cjBJNE82M2IxbzVjSjZHZFlzY3JvOUNHVnNBMzJxVmRvejFCTVRQTm1wbEZISjhNSnk1RFFzZ3dDQlpDYTA4ME80RFAxNmxEMVFCT3Bvdm0wUU5Ud0dEX2FyeXRvQmRTSXprYTRHcHZubFYza29qY2VKTGxVMEVYVkI0cXB3Nk85WlhaSWJpNC02MWRrZjllWXZBMjA0dG9rb0ppNWpSV1NuRGxqeVMyeG9RWDBHU1g4V3BMamVR?oc=5",
"published": "2026-07-30",
"age_days": 0,
"source": "StockStory",
"snippet": "Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full-Year Outlook Slightly Exceeds Expectations StockStory",
"relevance": 1.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Illumina Inc (ILMN) (Q2 2026) Earnings Call Highlights: Strong Clinical Growth Drives Revenue ...",
"link": "https://finance.yahoo.com/healthcare/articles/illumina-inc-ilmn-q2-2026-050415404.html?.tsrc=rss",
"published": "2026-07-31",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Illumina Inc (ILMN) reports 9.5% revenue growth in Q2 2026, led by robust clinical demand and NovaSeq X placements, prompting an upward revision to full-year EPS guidance.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 3.0,
"negative_hits": 0.0
},
{
"title": "Illumina (ILMN) Q2 2026 Earnings Call Transcript",
"link": "https://www.fool.com/earnings/call-transcripts/2026/07/30/illumina-ilmn-q2-2026-earnings-call-transcript/?.tsrc=rss",
"published": "2026-07-31",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Clinical momentum and NovaSeq X placements drive revenue guidance raise.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Illumina (ILMN) Reports Q2 Earnings: What Key Metrics Have to Say",
"link": "https://finance.yahoo.com/markets/stocks/articles/illumina-ilmn-reports-q2-earnings-233003165.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026",
"link": "https://finance.yahoo.com/healthcare/articles/illumina-reports-financial-results-second-200500493.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Illumina, Inc. (Nasdaq: ILMN) (\"Illumina\" or the \"company\") today announced its financial results for the second quarter of fiscal year 2026.",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Illumina Inc. Profit Retreats In Q2",
"link": "https://www.nasdaq.com/articles/illumina-inc-profit-retreats-q2",
"published": "2026-07-30",
"age_days": 1,
"source": "RTTNews",
"snippet": "(RTTNews) - Illumina Inc. (ILMN) revealed earnings for second quarter that Drops, from the same period last year",
"relevance": 1.35,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "Illumina Q2 26 Earnings Conference Call At 4:30 PM ET",
"link": "https://www.nasdaq.com/articles/illumina-q2-26-earnings-conference-call-4-30-pm-et",
"published": "2026-07-30",
"age_days": 1,
"source": "RTTNews",
"snippet": "(RTTNews) - Illumina Inc. (ILMN) will host a conference call at 4:30 PM ET on July 30, 2026, to discuss Q2 26 earnings results.",
"relevance": 1.35,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 1.0,
"positive_hits": 5.0,
"negative_hits": 0.0,
"news_sources": [
"RTTNews",
"StockStory",
"Yahoo Finance",
"quiverquant.com"
],
"catalysts": [
"业绩/指引",
"市场观点"
],
"news_errors": []
},
{
"symbol": "RTX",
"name": "RTX Corporation Common Stock",
"sector": "Industrials",
"industry": "Aerospace",
"exchange": "NYSE",
"market_cap": 288932390911.0,
"dollar_volume": 1123049138.58,
"price": 214.3800048828125,
"last_date": "2026-07-30",
"return_1d": -0.004041789162311238,
"return_5d": 0.0249569761393571,
"return_20d": 0.11784339476153627,
"return_60d": 0.23990753297054646,
"return_120d": 0.0939429685535178,
"ma20_distance": 0.06322939003620465,
"ma50_distance": 0.1305280760456018,
"ma200_distance": 0.14293241742882445,
"high_52w": 218.5800018310547,
"near_52w_high": 0.980785081374972,
"volume_ratio": 1.3311643930275625,
"volume_ratio_1d": 0.9873306078142157,
"volatility_20d": 0.33744450809866516,
"drawdown_52w": -0.019214918625028,
"trend_score": 1.0,
"sector_score": 0.46153846153846156,
"rs_20d": 0.12330092435674456,
"rs_60d": 0.20692750155913076,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.7839875678124767,
"research_score": 63.30369678864824,
"heat_score": 46.18640776699029,
"breakdown": {
"research_quality": 63.30369678864824,
"market_heat": 46.18640776699029,
"macro_event": 10.975825949374673,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.712621359223301,
"news": 8.95,
"relative_strength": 12.22135922330097,
"volume": 6.8970873786407765,
"liquidity": 4.613592233009708
},
"score": 56.315105332960385,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "How Much RTX Are You Quietly Betting On?",
"link": "https://www.trefis.com/articles/609481/how-much-rtx-are-you-quietly-betting-on/2026-07-30?.tsrc=rss",
"published": "2026-07-31",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Your diversified fund may have quietly made a concentrated bet on this one high-flying aerospace stock for you.",
"relevance": 1.6500000000000001,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "How RTX’s Q2 Beat, Raised Outlook and Record Backlog Will Impact RTX (RTX) Investors",
"link": "https://finance.yahoo.com/markets/stocks/articles/rtx-q2-beat-raised-outlook-220854563.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "RTX Corporation recently reported past second-quarter 2026 results, with revenue rising to US$24.71 billion from US$21.58 billion and net income increasing to US$2.14 billion from US$1.66 billion year over year, lifting basic earnings per share from continuing operations to US$1.58. Alongside this earnings beat, RTX boosted its full-year 2026 sales and profit outlook on the back of a sharply higher US$289 billion backlog spanning commercial aftermarket and defense programs. Next, we’ll...",
"relevance": 1.6500000000000001,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 4.0,
"negative_hits": 0.0
},
{
"title": "Morgan Stanley delivers strong new verdict on RTX stock after earnings",
"link": "https://www.thestreet.com/investing/stocks/rtxcorp-rtx-stock-price-target-after-q2-2026-earnings-morgan-stanley-july-2026?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Besides this second quarter, I had the chance to cover Morgan Stanley's note on RTX in April after their impressive Q1. Morgan Stanley cut RTX's price target to $220 but maintained an Overweight rating, viewing the post-earnings dip as a \"buying opportunity.\"Fast forward to this Q2 coverage: RTX ...",
"relevance": 1.6500000000000001,
"category": "分析师/评级",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 1.0
},
{
"title": "3 Industrial Stocks to Buy Amid Manufacturing Resilience",
"link": "https://www.nasdaq.com/articles/3-industrial-stocks-buy-amid-manufacturing-resilience",
"published": "2026-07-30",
"age_days": 1,
"source": "Zacks",
"snippet": "Crown Holdings, RTX and Kaiser Aluminum are highlighted as industrial stocks benefiting from resilient manufacturing, AI infrastructure demand and infrastructure spending.",
"relevance": 1.35,
"category": "医药/审批",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "EMBJ or RTX: Which Is the Better Value Stock Right Now?",
"link": "https://www.nasdaq.com/articles/embj-or-rtx-which-better-value-stock-right-now",
"published": "2026-07-29",
"age_days": 2,
"source": "Zacks",
"snippet": "EMBJ vs. RTX: Which Stock Is the Better Value Option?",
"relevance": 1.35,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "The Zacks Analyst Blog Highlights Alphabet, Advanced Micro Devices and RTX",
"link": "https://www.nasdaq.com/articles/zacks-analyst-blog-highlights-alphabet-advanced-micro-devices-and-rtx",
"published": "2026-07-29",
"age_days": 2,
"source": "Zacks",
"snippet": "Alphabet's AI momentum across Search and Cloud, alongside updates on AMD and RTX, highlights growth opportunities and key execution risks investors are watching.",
"relevance": 1.0,
"category": "分析师/评级",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 1.0
},
{
"title": "Get Paid 8.3% A Year To Hold RTX Stock You Already Own",
"link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNaDM5WHhLRHFILVFGVnMyUjY0ZEFvbHZQaGZ0YkV1VkZKakdLazczcTZwU1VYR09YMTJjNERXVjdMNlFxNzFUWE1xbDFGdG9EQWtRNEVDaHBmUjBURU5Qd0lmYVhyUU16bEpfSXlRNnpDakF1ZmxxUXZTdlFQb2dxNnVpMmZ3bjFvYVRRcUU3c05EVlVCZk83a200VW5BVl9rUDZOTE94YTFVLUZvdzRuTVpTYw?oc=5",
"published": "2026-07-24",
"age_days": 6,
"source": "Trefis",
"snippet": "Get Paid 8.3% A Year To Hold RTX Stock You Already Own Trefis",
"relevance": 1.35,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "RTX (NYSE:RTX) Reports Upbeat Q2 CY2026, Stock Soars",
"link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQR3d5dWpISVNYVzJmYjNJY05xZll6VGRlSFE1Ymk0cS00R0dpcmtfUGh0ZGFqaHpmcm4zSnNXM3phSDhxeGJRVUpIZnNHSVV0UjJlV3ZENm5pdUdheC1OS3VzcEcwSkpNVkRBTDZkR1BEWGRQY0ZGVzlLZGs3ZlBUVzZPVXd1dXhRQkhHQ1Y0Ti16U2lyUVBn?oc=5",
"published": "2026-07-23",
"age_days": 7,
"source": "Yahoo Finance",
"snippet": "RTX (NYSE:RTX) Reports Upbeat Q2 CY2026, Stock Soars Yahoo Finance",
"relevance": 1.6500000000000001,
"category": "市场观点",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "RTX Stock Rises After Strong Earnings but Faces 2 Iran War Headwinds",
"link": "https://news.google.com/rss/articles/CBMidEFVX3lxTE5YcWl5SDlTYWh3OFNqaS15YW1TSDdScDN2ZHY1Z0d3UmpqdjVFNVhlUE5kcHhKby1FZ2tFS0gwSVRGRGVfanBEQkxfdS1rREpRdFNfcFU5OTZDWmQwckROd291RjlTVTEtdG9qODVxWDEtZ1BN?oc=5",
"published": "2026-07-23",
"age_days": 7,
"source": "Barron's",
"snippet": "RTX Stock Rises After Strong Earnings but Faces 2 Iran War Headwinds Barron's",
"relevance": 1.35,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
}
],
"news_score": 0.8949999999999999,
"positive_hits": 7.300000000000001,
"negative_hits": 2.0,
"news_sources": [
"Barron's",
"Trefis",
"Yahoo Finance",
"Zacks"
],
"catalysts": [
"业绩/指引",
"分析师/评级",
"医药/审批",
"市场观点"
],
"news_errors": []
},
{
"symbol": "MET",
"name": "MetLife Inc. Common Stock",
"sector": "Finance",
"industry": "Life Insurance",
"exchange": "NYSE",
"market_cap": 62458408138.0,
"dollar_volume": 567013923.23,
"price": 97.06999969482422,
"last_date": "2026-07-30",
"return_1d": 0.0005153891309825909,
"return_5d": 0.0489517909496453,
"return_20d": 0.11318810885326513,
"return_60d": 0.22951239324886985,
"return_120d": 0.28876792469629553,
"ma20_distance": 0.04133925210628542,
"ma50_distance": 0.10093637557147761,
"ma200_distance": 0.21874433174942953,
"high_52w": 97.48999786376953,
"near_52w_high": 0.9956918845199668,
"volume_ratio": 1.2661908374231456,
"volume_ratio_1d": 1.4688873894074208,
"volatility_20d": 0.19796884242125376,
"drawdown_52w": -0.004308115480033181,
"trend_score": 1.0,
"sector_score": 0.8461538461538461,
"rs_20d": 0.11864563844847342,
"rs_60d": 0.19653236183745415,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.7464099037666391,
"research_score": 63.47075802837939,
"heat_score": 47.469902912621365,
"breakdown": {
"research_quality": 63.47075802837939,
"market_heat": 47.469902912621365,
"macro_event": 10.449738652732947,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.8368932038834953,
"news": 7.3549999999999995,
"relative_strength": 12.046601941747573,
"volume": 6.524271844660194,
"liquidity": 3.122330097087379
},
"score": 56.20164724541476,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "MetLife 2025 Sustainability Report: Expanding Access to Financial Services",
"link": "https://finance.yahoo.com/small-business/articles/metlife-2025-sustainability-report-expanding-131000669.html?.tsrc=rss",
"published": "2026-07-27",
"age_days": 3,
"source": "Yahoo Finance",
"snippet": "NORTHAMPTON, MA / ACCESS Newswire / July 27, 2026 /MetLife Through digital distribution and local partnerships, we develop solutions to meet customers where they are, expanding access to resources, care and financial support across communities.1 This ...",
"relevance": 1.6500000000000001,
"category": "产品/订单",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "MetLife (MET) Stock Looks Below Fair Value While Earnings Sit Above Fair Value",
"link": "https://finance.yahoo.com/markets/stocks/articles/metlife-met-stock-looks-below-151246523.html?.tsrc=rss",
"published": "2026-07-25",
"age_days": 5,
"source": "Yahoo Finance",
"snippet": "MetLife stock has nearly doubled investors' money over the past five years, yet there is a clear split in what the current price implies, with the Excess Returns intrinsic value estimate pointing to a sizeable discount while earnings-based multiples lean in the opposite direction. Over the past five years, MetLife has delivered a 91.4% total return, which puts more pressure on today's valuation to be supported by future cash flows rather than past price gains. The valuation can be helped if...",
"relevance": 2.0,
"category": "业绩/指引",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "MetLife, Inc. $MET Shares Purchased by Inceptionr LLC",
"link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOWUtQSTdpM2xUbDRnRWQ2TGdKaHRnQm1LUUw0RUtDQWZvYm94SVVzQnhYMEY5YVYzS1hQXzItZDA2cVBzZXJOaUwwYTdjdHMtV2tzdFlTdVpsT19YdmtBcDJyTTJ0UkVnSGtqbnhwUWdvME9rUDByWnVmU1JTYVgxblA5VFFZRmJKalphMU1tNGs0dWs2RTVwcExjTjJOTVVKZFpqbHpvSnVmYWVOcnNrVg?oc=5",
"published": "2026-07-24",
"age_days": 6,
"source": "MarketBeat",
"snippet": "MetLife, Inc. $MET Shares Purchased by Inceptionr LLC MarketBeat",
"relevance": 1.35,
"category": "市场观点",
"sentiment": "positive",
"freshness": 0.65,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "CORRECTING and REPLACING Everest and MetLife Expand Bereavement and Legacy Support to Ireland",
"link": "https://finance.yahoo.com/healthcare/articles/everest-metlife-expand-bereavement-legacy-111500131.html?.tsrc=rss",
"published": "2026-07-22",
"age_days": 8,
"source": "Yahoo Finance",
"snippet": "DUBLIN, July 22, 2026--Update to the Wayne Gibbons quote in the release, dated July 7, 2026.",
"relevance": 1.6500000000000001,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Lobbying Update: $370,000 of METLIFE GROUP INC. lobbying was just disclosed",
"link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQeUFqbHNJUkJBbG1SZUQtSTBWSU02X2o3NG9ITGJMYlQyOHdLZVpWYzNFdEdEODNXelRUNDBfVmcwMFFFYVdtRmpBMGc4MEZ2UzV4YzN5dHotVXA5MWRxaVFlbTlMNGlkMmYzSWVBbWhzRnhqWUNFZnpTOEYzTFpCTkRKY3NrWFhnNWZVbk5ONXlUTWNsUmVtRlEtRUhVQ0dqc25DQ2dpQ3pmR19zY3lvV18wUlI?oc=5",
"published": "2026-07-20",
"age_days": 10,
"source": "quiverquant.com",
"snippet": "Lobbying Update: $370,000 of METLIFE GROUP INC. lobbying was just disclosed quiverquant.com",
"relevance": 1.35,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.65,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Is MetLife (MET) Fairly Valued On Its Fresh Dividend Declaration?",
"link": "https://news.google.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?oc=5",
"published": "2026-07-15",
"age_days": 15,
"source": "simplywall.st",
"snippet": "Is MetLife (MET) Fairly Valued On Its Fresh Dividend Declaration? simplywall.st",
"relevance": 1.35,
"category": "并购/资本",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "How AI Is Becoming MetLife's Long-Term Competitive Advantage",
"link": "https://www.nasdaq.com/articles/how-ai-becoming-metlifes-long-term-competitive-advantage",
"published": "2026-07-15",
"age_days": 16,
"source": "Zacks",
"snippet": "MET is embedding AI across underwriting, claims and service to boost efficiency, improve customer experiences and strengthen long-term competitiveness.",
"relevance": 1.35,
"category": "产品/订单",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "MET November 20th Options Begin Trading",
"link": "https://www.nasdaq.com/articles/met-november-20th-options-begin-trading",
"published": "2026-07-13",
"age_days": 18,
"source": "BNK Invest",
"snippet": "Investors in MetLife Inc (Symbol: MET) saw new options become available today, for the November 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 130 days until expiration the newly available contr",
"relevance": 1.35,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Metlife stock reaches all-time high at 92.49 USD",
"link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNcU5CYXZfaGUzZFBQVVU1MDE5V0tHVnNsdHdmRjRqdGd2UWxYeU83ek96TDY4YWgxTVYwLTBiSXN6NFA4c0JmOUx6MFlkR2pmY1JkcW1HUmgwUXlaUEFHdk00Z0VVQi1uRkxhLUh6NjZ0dGlwS081YkhtSW9CcVdUZzBlakluZjBlcUQzLVZtSHRxZmcxMVJkekRiMEJ5S2xOanlPSmxn?oc=5",
"published": "2026-07-10",
"age_days": 20,
"source": "Investing.com",
"snippet": "Metlife stock reaches all-time high at 92.49 USD Investing.com",
"relevance": 1.7,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 0.3,
"positive_hits": 0.0,
"negative_hits": 0.0
}
],
"news_score": 0.7354999999999999,
"positive_hits": 0.65,
"negative_hits": 0.0,
"news_sources": [
"BNK Invest",
"Investing.com",
"MarketBeat",
"Yahoo Finance",
"Zacks",
"quiverquant.com",
"simplywall.st"
],
"catalysts": [
"业绩/指引",
"产品/订单",
"市场观点"
],
"news_errors": []
},
{
"symbol": "KO",
"name": "Coca-Cola Company (The) Common Stock",
"sector": "Consumer Staples",
"industry": "Beverages (Production/Distribution)",
"exchange": "NYSE",
"market_cap": 380874488086.0,
"dollar_volume": 1558803116.6499999,
"price": 88.48999786376953,
"last_date": "2026-07-30",
"return_1d": -0.006623304391081275,
"return_5d": 0.09018109966675802,
"return_20d": 0.08857174150759417,
"return_60d": 0.13173033764875308,
"return_120d": 0.12711750676330102,
"ma20_distance": 0.05562015458016689,
"ma50_distance": 0.08043493356029408,
"ma200_distance": 0.16467845288117222,
"high_52w": 89.08000183105469,
"near_52w_high": 0.9933766956089187,
"volume_ratio": 1.0701871213296554,
"volume_ratio_1d": 0.8873554579908888,
"volatility_20d": 0.3126683700203786,
"drawdown_52w": -0.006623304391081275,
"trend_score": 1.0,
"sector_score": 0.7692307692307693,
"rs_20d": 0.09402927110280246,
"rs_60d": 0.09875030623733738,
"entry_setup_score": 1.0,
"overheat_score": 0.0,
"macro_fit": 0.794480579674099,
"research_score": 62.4386855862584,
"heat_score": 45.596116504854365,
"breakdown": {
"research_quality": 62.4386855862584,
"market_heat": 45.596116504854365,
"macro_event": 11.122728115437386,
"entry_setup": 7.0,
"overheat_penalty": -0.0,
"near_52w_high": 3.8213592233009708,
"news": 10.0,
"relative_strength": 10.586407766990291,
"volume": 4.7223300970873785,
"liquidity": 5.137864077669903
},
"score": 55.88440495984147,
"is_near_high": true,
"is_high_volume": false,
"items": [
{
"title": "Pepsi kills the bottle that was supposed to beat Mexican Coke",
"link": "https://www.thestreet.com/retail/pepsico-silently-discontinued-a-product-coca-cola-still-offers?.tsrc=rss",
"published": "2026-07-31",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "Coca-Cola's glass bottle has become one of the most recognizable pieces of packaging in history. PepsiCo has spent decades trying to create a similar connection with consumers. \"Every consumer goods company wants to find a unique way to present itself to the public, and this, for us, has been the ...",
"relevance": 1.0,
"category": "业绩/指引",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
},
{
"title": "The Coca-Cola Company: Volume Scale Beats CPG Stagflation as FIFA Activation Drives Guidance Upgrade",
"link": "https://finance.yahoo.com/markets/stocks/articles/coca-cola-company-volume-scale-131924953.html?.tsrc=rss",
"published": "2026-07-30",
"age_days": 0,
"source": "Yahoo Finance",
"snippet": "The Consumer Packaged Goods (CPG) industry is going through a major shift this year, with broad inflation-driven price hikes having reached their peak. With core inflation hovering around 2.5%, CPG growth has shifted firmly back to a volume-driven imperative. Broader national brand unit volumes across the sector fell 0.6% year-to-date, indicating a polarized consumer base […]",
"relevance": 1.0,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 5.0,
"negative_hits": 0.0
},
{
"title": "Coca-Cola (KO) Stock Jumps On Margin Gains And Strong Cash Flow",
"link": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQZHFZQzBFcjNzOHBFSmF6SFlZWlU5MlhaUndDd1ZOVTRwcUpuOHNQTDlZSk5wZENJY2Zka2VGSThyWXVvbU9KTUhjWi0tQ1cxRktFV2VIaTlhMW1UNlFEdENLS2U5cHZwWFR5dThkUkhlUUMwR3JlZVlKT1p5ekNVbG91cHlEeFZ1VnV4YzN4TVMxS1BfQ3ZpV2YydEtRNWs3SHkyZEF5cTJsSUVBY1pWa0V2akpGZFhXeG1uQ0VDTEJoUl9obzYyZFNwOWxHa2FHaG9N0gHYAUFVX3lxTFBCdUxybWRDVGZ3M1ZZQmNPaS1nd1JnbkdhYmQ0dlRqdmV2M3dVbllEWG1CeHdqekF2cHF6YnVCOHl1Y0lnU3RtdjN3ODVtZ1hrcXhLYUdUVk1Td0NnZVUyc29yQ2VRcU1lZDJuYlRUWUNkOTVyMWNIWGxSYlhZVUEybl9VRDJKUDB4OFBGZlVpSVFTZ2lMSWJYb0dNQmRYb3dMRjNQcjRnaHUxUGNqU0kxMmRXQ0k4OHItOElxT25Va0NKZllwUGFhamRUR2llMTd5ZFM3ZXZ3cQ?oc=5",
"published": "2026-07-29",
"age_days": 1,
"source": "simplywall.st",
"snippet": "Coca-Cola (KO) Stock Jumps On Margin Gains And Strong Cash Flow simplywall.st",
"relevance": 1.35,
"category": "市场观点",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 2.0,
"negative_hits": 0.0
},
{
"title": "How Much Track Is Left For KO Stock?",
"link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOaHBiRUpuR3Z5VkMxSGJKaC1EbWhjRS1XeDBkYXE5Mk1BT0FleXB3X0hRM3NhS1F2QzF0OFgtaWJkaW1iTWJFdk11UldvYWZ5cHN6c1BtOWNhcEdzbXpTTTNvNFRJcXVpZnJIaDZ6dlZBaWhTNk9vZ1ZZR3JRdkp1RkZjX2NqY2hmYTZPZFM4LWpPU1k2blNNZGZR?oc=5",
"published": "2026-07-29",
"age_days": 1,
"source": "Trefis",
"snippet": "How Much Track Is Left For KO Stock? Trefis",
"relevance": 1.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "Coca-Cola hikes full-year forecast. CEO tells CNBC the World Cup boosted its brands",
"link": "https://news.google.com/rss/articles/CBMidEFVX3lxTE44N0RXQ1dNenhKNVJoLXJSTmFBMll6WE1BQUg2RUFja2Rzby1oVTgwRHl3dEdMamRLSTFjeWtkajFibVdXREs0NlU5OU9yeWhkOFdVMUp6d0h3ZHJ4aHNKVXQ0bVlpNm8zNHhoNEdDUHRVSVFh0gF6QVVfeXFMTWMzRV9ybTg4cFVfOEVDSnhELVpua3k1SEphTHBkQkVrdWhFRC1neUFLOFBhekxicVpLVTE1ajZsTm5FTGFqbzZ0QmhHR2tGc0owWVVway1wRWdsaXhSQVRqQlpvYkdkRmxFbzJuQlY0OUtydkxCcE5vQWc?oc=5",
"published": "2026-07-28",
"age_days": 2,
"source": "CNBC",
"snippet": "Coca-Cola hikes full-year forecast. CEO tells CNBC the World Cup boosted its brands CNBC",
"relevance": 1.35,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "SPY is up 0.4% today, on KO stock price movement",
"link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxObnU2Ul9lbzlhbEhBZUxQQmFPQXNkdXBMSFhpSU1uTnFVc1gzSk1OXzNzWkhmSjBYaHRaaDVDd01yQ1ZPaF93ZE5PQW0tUURUM2lXc1FsMmtNY1hwS21YTXROb1k4RFBJU3VSb2VpaVh2MDlJWkFaZWJqTXpzSkxnbG90dGRsajMyRmVsSlBR?oc=5",
"published": "2026-07-28",
"age_days": 2,
"source": "quiverquant.com",
"snippet": "SPY is up 0.4% today, on KO stock price movement quiverquant.com",
"relevance": 1.0,
"category": "市场观点",
"sentiment": "neutral",
"freshness": 1.0,
"positive_hits": 0.0,
"negative_hits": 0.0
},
{
"title": "KO Stock Rises Overnight After Earnings Beat, But Analyst Sees Limited Upside – Says PepsiCo Offers Better Value",
"link": "https://news.google.com/rss/articles/CBMihAJBVV95cUxObmszWDQ4TUFZQXJHUktZajdKOE9SRFFtUl93MU5XbU1fcjlkMVRNdVRpV1NBV3JpTWhDV2FZUTVLaVB4emQ1M052UmllcFE4bHpOeDRkTkpPck9oblpzZmZseUdEZmlzanY3WGJrMk9SREUxN21XcTV5LWZRZ2FmbWFmVUdtRGRfWVlSamNfWWpWT1h1ZEtFczVISnhOMFhwLXpSVlZlYnd1dkxRdlg0T0FqZ0V3dXRsQ09EdTF4TC1UdlpFMlE1MUtwZ0c1V0p2RjZnbUk4Si14Mlozc3FHUUU0QlZ1azF5bnlKQ3FSLWMwTkh0SEhjNVZQRzUwREt1eHVmUg?oc=5",
"published": "2026-07-29",
"age_days": 2,
"source": "Stocktwits",
"snippet": "KO Stock Rises Overnight After Earnings Beat, But Analyst Sees Limited Upside – Says PepsiCo Offers Better Value Stocktwits",
"relevance": 1.0,
"category": "分析师/评级",
"sentiment": "positive",
"freshness": 1.0,
"positive_hits": 1.0,
"negative_hits": 0.0
}
],
"news_score": 1.0,
"positive_hits": 9.0,
"negative_hits": 0.0,
"news_sources": [
"CNBC",
"Stocktwits",
"Trefis",
"Yahoo Finance",
"quiverquant.com",
"simplywall.st"
],
"catalysts": [
"业绩/指引",
"分析师/评级",
"市场观点"
],
"news_errors": []
}
],
"sources": [
"Nasdaq screener: exchange, sector, market cap, latest price and volume",
"Yahoo Finance chart endpoint: daily prices, volume, SPY/QQQ/VIX/^TNX macro tape",
"Yahoo Finance RSS / Nasdaq news / Google News RSS: company catalysts",
"Google News RSS: macro event headlines (FOMC, CPI/NFP, geopolitics, commodities)",
"Unified score: research quality + market heat + macro-event fit"
]
}